EDP Sciences logo
Web of Conferences logo
Search
Menu
All issues Volume 136 (2019) E3S Web Conf., 136 (2019) 06012 References
Open Access
Issue
E3S Web Conf.
Volume 136, 2019
2019 International Conference on Building Energy Conservation, Thermal Safety and Environmental Pollution Control (ICBTE 2019)
Article Number 06012
Number of page(s) 5
Section Monitoring and Treatment of Water Pollution
DOI https://doi.org/10.1051/e3sconf/201913606012
Published online 10 December 2019
  1. An, X. Q.; Xi, W.; Gu, C. Y.; Huang, X., Complement protein C5a enhances the beta-amyloid-induced neuro-inflammatory response in microglia in Alzheimer’s disease. Med Sci (Paris) 2018, 34 Focus issue F1, 116-120. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Ajona, D.; Ortiz-Espinosa, S.; Pio, R., Complement anaphylatoxins C3a and C5a: Emerging roles in cancer progression and treatment. Semin Cell Dev Biol 2019, 85, 153-163. [CrossRef] [PubMed] [Google Scholar]
  3. Clark, A.; Weymann, A.; Hartman, E.; Turmelle, Y.; Carroll, M.; Thurman, J. M.; Holers, V. M.; Hourcade, D. E.; Rudnick, D. A., Evidence for non-traditional activation of complement factor C3 during murine liver regeneration. Mol Immunol 2008, 45 (11), 3125-32. [Google Scholar]
  4. Merle, N. S.; Noe, R.; Halbwachs-Mecarelli, L.; Fremeaux-Bacchi, V.; Roumenina, L. T., Complement System Part II: Role in Immunity. Front Immunol 2015, 6, 257. [PubMed] [Google Scholar]
  5. Ajona, D.; Zandueta, C.; Corrales, L.; Moreno, H.; Pajares, M. J.; Ortiz-Espinosa, S.; Martinez-Terroba, E.; Perurena, N.; de Miguel, F. J.; Jantus-Lewintre, E.; Camps, C.; Vicent, S.; Agorreta, J.; Montuenga, L. M.; Pio, R.; Lecanda, F., Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects. Am J Respir Crit Care Med 2018, 197 (9), 1164-1176. [CrossRef] [PubMed] [Google Scholar]
  6. Broker, K.; Figge, J.; Magnusen, A. F.; Manz, R. A.; Kohl, J.; Karsten, C. M., A Novel Role for C5a in B-1 Cell Homeostasis. Front Immunol 2018, 9, 258. [CrossRef] [PubMed] [Google Scholar]
  7. Colley, C. S.; Popovic, B.; Sridharan, S.; Debreczeni, J. E.; Hargeaves, D.; Fung, M.; An, L.; Edwards, B.; Arnold, J.; England, E.; Eghobamien, L.; Sivars, U.; Flavell, L.; Renshaw, J.; Wickson, K.; Warrener, P.; Zha, J. Y.; Bonnell, J.; Woods, R.; Wilkinson, T.; Dobson, C.; Vaughan, T. J., Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors. Mabs 2018, 10 (1), 104-117. [CrossRef] [PubMed] [Google Scholar]
  8. Ali, H., Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a. Immunol Lett 2010, 128 (1), 36-45. [CrossRef] [PubMed] [Google Scholar]
  9. Foersch, S.; Sperka, T.; Lindner, C.; Taut, A.; Rudolph, K. L.; Breier, G.; Boxberger, F.; Rau, T. T.; Hartmann, A.; Sturzl, M.; Wittkopf, N.; Haep, L.; Wirtz, S.; Neurath, M. F.; Waldner, M. J., VEGFR2 Signaling Prevents Colorectal Cancer Cell Senescence to Promote Tumorigenesis in Mice With Colitis. Gastroenterology 2015, 149 (1), 177-189 e10. [CrossRef] [PubMed] [Google Scholar]
  10. Chen, J.; Li, G. Q.; Zhang, L.; Tang, M.; Cao, X.; Xu, G. L.; Wu, Y. Z., Complement C5a/C5aR pathway potentiates the pathogenesis of gastric cancer by down-regulating p21 expression. Cancer Lett 2018, 412, 30-36. [Google Scholar]
  11. Freund, A.; Jolivel, V.; Durand, S.; Kersual, N.; Chalbos, D.; Chavey, C.; Vignon, F.; Lazennec, G., Mechanisms underlying differential expression of interleukin-8 in breast cancer cells. Oncogene 2004, 23 (36), 6105-14. [Google Scholar]
  12. Freund, A.; Jolivel, V.; Durand, S.; Kersual, N.; Chalbos, D.; Chavey, C.; Vignon, F.; Lazennec, G., Mechanisms underlying differential expression of interleukin-8 in breast cancer cells. Oncogene 2004, 23 (36), 6105-14. [Google Scholar]
  13. Sarvaiya, P. J.; Guo, D.; Ulasov, I.; Gabikian, P.; Lesniak, M. S., Chemokines in tumor progression and metastasis. Oncotarget 2013, 4 (12), 2171-85. [CrossRef] [PubMed] [Google Scholar]
  14. Bjorge, L.; Hakulinen, J.; Vintermyr, O. K.; Jarva, H.; Jensen, T. S.; Iversen, O. E.; Meri, S., Ascitic complement system in ovarian cancer. Br J Cancer 2005, 92 (5), 895-905. [CrossRef] [PubMed] [Google Scholar]
  15. Xi, W.; Liu, L.; Wang, J.; Xia, Y.; Bai, Q.; Xiong, Y.; Qu, Y.; Long, Q.; Xu, J.; Guo, J., Enrichment of C5a-C5aR axis predicts poor postoperative prognosis of patients with clear cell renal cell carcinoma. Oncotarget 2016, 7 (49), 80925-80934. [PubMed] [Google Scholar]
  16. Kaida, T.; Nitta, H.; Kitano, Y.; Yamamura, K.; Arima, K.; Izumi, D.; Higashi, T.; Kurashige, J.; Imai, K.; Hayashi, H.; Iwatsuki, M.; Ishimoto, T.; Hashimoto, D.; Yamashita, Y.; Chikamoto, A.; Imanura, T.; Ishiko, T.; Beppu, T.; Baba, H., C5a receptor (CD88) promotes motility and invasiveness of gastric cancer by activating RhoA. Oncotarget 2016, 7 (51), 84798-84809. [CrossRef] [PubMed] [Google Scholar]
  17. Gonda, T. A.; Tu, S.; Wang, T. C., Chronic inflammation, the tumor microenvironment and carcinogenesis. Cell Cycle 2009, 8 (13), 2005-13. [CrossRef] [PubMed] [Google Scholar]
  18. Khan, M. A.; Assiri, A. M.; Broering, D. C., Complement and macrophage crosstalk during process of angiogenesis in tumor progression. J Biomed Sci 2015, 22, 58. [CrossRef] [PubMed] [Google Scholar]
  19. Markiewski, M. M.; DeAngelis, R. A.; Benencia, F.; Ricklin-Lichtsteiner, S. K.; Koutoulaki, A.; Gerard, C.; Coukos, G.; Lambris, J. D., Modulation of the antitumor immune response by complement. Nat Immunol 2008, 9 (11), 1225-35. [CrossRef] [PubMed] [Google Scholar]
  20. Corrales, L.; Ajona, D.; Rafail, S.; Lasarte, J. J.; Riezu-Boj, J. I.; Lambris, J. D.; Rouzaut, A.; Pajares, M. J.; Montuenga, L. M.; Pio, R., Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression. J Immunol 2012, 189 (9), 4674-83. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.